CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited

BMC Cell Biology

Andrew D Chalmers³  Dave H Kelly²  Adam D Pope²  Katrina James³  Christopher J Caunt¹  Paul Whitley¹  Ben Sharpe¹  Gail Doughton¹  Chris Bryant¹  Tulay Gulsen¹  Joe R Fenn³  Paul M Leader²  Matthew A Helsby³ 

[1] Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK;Storm Consultancy, 14 New Bond Street, Bath BA1 1BE, UK;CiteAb, Carpenter House, Bath BA1 1UD, UK

关键词: Citations;    Species reactivity;    ChIP host species;    Immunohistochemistry;    Flow cytometry;    Western blotting;    Polyclonal;    Monoclonal;    Antibodies;   

Others  :  854992
DOI  :  10.1186/1471-2121-15-6

 received in 2013-10-08, accepted in 2014-01-29,  发布年份 2014

【 摘 要 】

Background

Research antibodies are used by thousands of scientists working in diverse disciplines, but it is common to hear concerns about antibody quality. This means that researchers need to carefully choose the antibodies they use to avoid wasting time and money. A well accepted way of selecting a research antibody is to identify one which has been used previously, where the associated data has been peer-reviewed and the results published.

Description

CiteAb is a searchable database which ranks antibodies by the number of times they have been cited. This allows researchers to easily find antibodies that have been used in peer-reviewed publications and the accompanying citations are listed, so users can check the data contained within the publications. This makes CiteAb a useful resource for identifying antibodies for experiments and also for finding information to demonstrate antibody validation. The database currently contains 1,400,000 antibodies which are from 90 suppliers, including 87 commercial companies and 3 academic resources. Associated with these antibodies are 140,000 publications which provide 306,000 antibody citations. In addition to searching, users can also browse through the antibodies and add their own publications to the CiteAb database.

Conclusions

CiteAb provides a new way for researchers to find research antibodies that have been used successfully in peer-reviewed publications. It aims to assist these researchers and will hopefully help promote progress in many areas of life science research.

【 授权许可】

   
2014 Helsby et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Bird C: Antibody User Survey. The Scientist 2012. [http://www.the-scientist.com/?articles.view/articleNo/32042/title/Antibodies-User-Survey/ webcite]
• [2]Couchman JR: Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem 2009, 57(1):7-8.
• [3]Kalyuzhny AE: The dark side of the immunohistochemical moon: industry. J Histochem Cytochem 2009, 57(12):1099-1101.
• [4]Pradidarcheep W, Labruyere WT, Dabhoiwala NF, Lamers WH: Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem 2008, 56(12):1099-1111.
• [5]Marx V: Finding the right antibody for the job. Nat Methods 2013, 10(8):703-707.
• [6]Barnard RM: Flow cytometry: a flexible tool for biomarker research. Bioanalysis 2012, 4(20):2471-2483.
• [7]Dickson C: Protein techniques: immunoprecipitation, in vitro kinase assays, and Western blotting. Methods Mol Biol 2008, 461:735-744.
• [8]Plested JS, Coull PA, Gidney MA: Elisa. Methods Mol Med 2003, 71:243-261.
• [9]Shi SR, Shi Y, Taylor CR: Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades. J Histochem Cytochem 2011, 59(1):13-32.
• [10]Bradford Y, Conlin T, Dunn N, Fashena D, Frazer K, Howe DG, Knight J, Mani P, Martin R, Moxon SA, et al.: ZFIN: enhancements and updates to the Zebrafish Model Organism Database. Nucleic Acids Res 2011, 39(Database issue):D822-D829.
• [11]James-Zorn C, Ponferrada VG, Jarabek CJ, Burns KA, Segerdell EJ, Lee J, Snyder K, Bhattacharyya B, Karpinka JB, Fortriede J, et al.: Xenbase: expansion and updates of the Xenopus model organism database. Nucleic Acids Res 2013, 41(Database issue):D865-D870.
• [12]Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, Chetvernin V, Church DM, Dicuccio M, Federhen S, et al.: Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2012, 40(Database issue):D13-D25.
• [13]Editorial: Reducing our irreproducibility. Nature 2013, 496:398.
• [14]Helsby MA, Fenn JR, Chalmers AD: Reporting research antibody use: how to increase experimental reproducibility. F1000Res 2013, 2(153):1-11.
• [15]Baek JH, Darlington CL, Smith PF, Ashton JC: Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB(2) receptor. J Neurosci Methods 2013, 216(2):87-95.
• [16]Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D: Antibody validation. Biotechniques 2010, 48(3):197-209.
• [17]Holmseth S, Zhou Y, Follin-Arbelet VV, Lehre KP, Bergles DE, Danbolt NC: Specificity controls for immunocytochemistry: the antigen preadsorption test can lead to inaccurate assessment of antibody specificity. J Histochem Cytochem 2012, 60(3):174-187.
• [18]Lorincz A, Nusser Z: Specificity of immunoreactions: the importance of testing specificity in each method. J Neurosci 2008, 28(37):9083-9086.
• [19]Michel MC, Wieland T, Tsujimoto G: How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 2009, 379(4):385-388.